Literature DB >> 25664034

The value of susceptibility weighted magnetic resonance imaging in evaluation of patients with familial cerebral cavernous angioma.

Haci Taner Bulut1, Mehmet Akif Sarica1, Ali Haydar Baykan1.   

Abstract

OBJECTIVES: We investigated the imaging features of Cavernous angioma (CA) lesions and the value of Susceptibility-weighted imaging (SWI) by comparing with T2*-weighted gradient echo (GRE) sequences in patients with familial CA disease.
MATERIAL AND METHODS: We retrospectively evaluated 19 familial CA patients (8 men, 11 women; mean age, 36 years). T1-weighted, T2-weighted, T2*-weighted GRE, and SWI sequences were performed to all patients. The numbers of CA lesions seen on T2*-weighted GRE and SWI sequences were analyzed. The correlations between the numbers of lesions on both sequences with age were evaluated. CA lesions were classified according to the classification of Zabramski et al.
RESULTS: The number of CA lesions was higher on SWI than T2*-weighted GRE significantly (P<.001). There was a significant strong correlation between the age of the patients and number of lesions in the cohort on T2*-weighted GRE (r = 0.81, P<0.001) and SWI (r = 0.85, P<0.001) sequences. Approximately 44% of the CA lesions which were detected only by SWI could not be categorized according to the classification of Zabramski et al.
CONCLUSION: SWI can provide helpful additional information by determining the CA lesions more accurately than T2*-weighted GRE. Thus, routine clinical neuroimaging protocols should contain SWI to assess the true prevalence of lesions for optimal diagnosis and treatment. Moreover, this study show that the Zabramski classification is insufficient to identify all CA lesions, and a new type (type V) should be added to represent lesions that are seen on SWI but not on T2*-weighted GRE.

Entities:  

Keywords:  Cavernous angioma; T2*-weighted gradient echo; cavernoma; cavernous malformation; susceptibility-weighted imaging

Year:  2014        PMID: 25664034      PMCID: PMC4307481     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  22 in total

1.  Macroscopic susceptibility in ultra high field MRI.

Authors:  A M Abduljalil; P M Robitaille
Journal:  J Comput Assist Tomogr       Date:  1999 Nov-Dec       Impact factor: 1.826

2.  Familial form of intracranial cavernous angioma: MR imaging findings in 51 families. French Society of Neurosurgery.

Authors:  L Brunereau; P Labauge; E Tournier-Lasserve; S Laberge; C Levy; J P Houtteville
Journal:  Radiology       Date:  2000-01       Impact factor: 11.105

3.  Cerebral cavernous malformations: spectrum of neuroradiological findings.

Authors:  J J Cortés Vela; L Concepción Aramendía; F Ballenilla Marco; J I Gallego León; J González-Spínola San Gil
Journal:  Radiologia       Date:  2011-12-24

4.  Classification and natural history of cerebral vascular malformations: arteriovenous, cavernous, and venous.

Authors:  D L Barrow
Journal:  J Stroke Cerebrovasc Dis       Date:  1997 Apr-May       Impact factor: 2.136

5.  The natural history of familial cerebral cavernomas: a retrospective MRI study of 40 patients.

Authors:  P Labauge; L Brunereau; C Lévy; S Laberge; J P Houtteville
Journal:  Neuroradiology       Date:  2000-05       Impact factor: 2.804

6.  Cerebral cavernous malformations. Incidence and familial occurrence.

Authors:  D Rigamonti; M N Hadley; B P Drayer; P C Johnson; K Hoenig-Rigamonti; J T Knight; R F Spetzler
Journal:  N Engl J Med       Date:  1988-08-11       Impact factor: 91.245

7.  Value of gradient-echo magnetic resonance imaging in the diagnosis of familial cerebral cavernous malformation.

Authors:  Fritz-Georg Lehnhardt; Ulrich von Smekal; Benedikt Rückriem; Werner Stenzel; Michael Neveling; Wolf-Dieter Heiss; Andreas H Jacobs
Journal:  Arch Neurol       Date:  2005-04

8.  The natural history of cavernous malformations: a prospective study of 68 patients

Authors: 
Journal:  Neurosurgery       Date:  1999-06       Impact factor: 4.654

Review 9.  Susceptibility-weighted imaging for differential diagnosis of cerebral vascular pathology: a pictorial review.

Authors:  Yu-Kun Tsui; Fong Y Tsai; Anton N Hasso; Fred Greensite; Binh V Nguyen
Journal:  J Neurol Sci       Date:  2009-09-20       Impact factor: 3.181

10.  The natural history of familial cavernous malformations: results of an ongoing study.

Authors:  J M Zabramski; T M Wascher; R F Spetzler; B Johnson; J Golfinos; B P Drayer; B Brown; D Rigamonti; G Brown
Journal:  J Neurosurg       Date:  1994-03       Impact factor: 5.115

View more
  10 in total

1.  Detection of cavernous malformations after whole-brain radiotherapy in primitive neuroectodermal tumor patients-comparing susceptibility-weighted imaging and T2 gradient-echo sequences.

Authors:  Vadim Khasminsky; Michal Yalon; Gahl Greenberg; Galia Tsarfaty; Eli Atar; Chen Hoffmann
Journal:  Neuroradiology       Date:  2018-07-20       Impact factor: 2.804

Review 2.  Neuroimaging of Cavernous Malformations.

Authors:  Maxim Mokin; Siviero Agazzi; Lowell Dawson; Christopher T Primiani
Journal:  Curr Pain Headache Rep       Date:  2017-10-13

3.  Novel loss of function mutation in KRIT1/CCM1 is associated with distinctly progressive cerebral and spinal cavernous malformations after radiochemotherapy for intracranial malignant germ cell tumor.

Authors:  Alexandra Russo; Marie Astrid Neu; Johanna Theruvath; Bettina Kron; Arthur Wingerter; Silla Hey-Koch; Yasemin Tanyildizi; Joerg Faber
Journal:  Childs Nerv Syst       Date:  2017-05-09       Impact factor: 1.475

4.  Susceptibility-Based Neuroimaging: Standard Methods, Clinical Applications, and Future Directions.

Authors:  Salil Soman; Jose A Bregni; Berkin Bilgic; Ursula Nemec; Audrey Fan; Zhe Liu; Robert L Barry; Jiang Du; Keith Main; Jerome Yesavage; Maheen M Adamson; Michael Moseley; Yi Wang
Journal:  Curr Radiol Rep       Date:  2017-02-14

5.  Identification of a Novel Deletion Mutation (c.1780delG) and a Novel Splice-Site Mutation (c.1412-1G>A) in the CCM1/KRIT1 Gene Associated with Familial Cerebral Cavernous Malformation in the Chinese Population.

Authors:  Chenlong Yang; Jizong Zhao; Bingquan Wu; Haohao Zhong; Yan Li; Yulun Xu
Journal:  J Mol Neurosci       Date:  2016-09-20       Impact factor: 3.444

6.  A Novel CCM1/KRIT1 Heterozygous Nonsense Mutation (c.1864C>T) Associated with Familial Cerebral Cavernous Malformation: a Genetic Insight from an 8-Year Continuous Observational Study.

Authors:  Chenlong Yang; Van Halm-Lutterodt Nicholas; Jizong Zhao; Bingquan Wu; Haohao Zhong; Yan Li; Yulun Xu
Journal:  J Mol Neurosci       Date:  2017-03-02       Impact factor: 3.444

7.  Accuracy of SWI sequences compared to T2*-weighted gradient echo sequences in the detection of cerebral cavernous malformations in the familial form.

Authors:  Gianvincenzo Sparacia; Claudia Speciale; Aurelia Banco; Francesco Bencivinni; Massimo Midiri
Journal:  Neuroradiol J       Date:  2016-08-22

8.  Cerebellar developmental venous anomaly with associated cavernoma causing a hemorrhage - a rare occurrence.

Authors:  Omar Marzouk; Sherief Marzouk; Sidath H Liyanage; Iris Q Grunwald
Journal:  Radiol Case Rep       Date:  2021-04-13

9.  Brain magnetic resonance imaging findings among children with epilepsy in two urban hospital settings, Kampala-Uganda: a descriptive study.

Authors:  Denise Apolot; Geoffrey Erem; Rita Nassanga; Daniel Kiggundu; Crescent Max Tumusiime; Anneth Teu; Alex Mwesigwa Mugisha; Robert Sebunya
Journal:  BMC Med Imaging       Date:  2022-10-06       Impact factor: 2.795

10.  KRIT1 Gene in Patients with Cerebral Cavernous Malformations: Clinical Features and Molecular Characterization of Novel Variants.

Authors:  Claudia Ricci; Alfonso Cerase; Giulia Riolo; Giuditta Manasse; Stefania Battistini
Journal:  J Mol Neurosci       Date:  2021-03-02       Impact factor: 3.444

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.